Tx360

DEVICE2 trials

Sponsors

Tian Medical Inc., Washington University School of Medicine

Conditions

Headache, MigraineMigraine in ChildrenPain, Neuropathic

Phase 2

Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients

WithdrawnNCT04466826

Washington University School of MedicineMigraine in Children, Pain, Neuropathic

Start: 2021-01-02End: 2021-02-05Updated: 2021-02-10

Phase 3

Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine

CompletedNCT03337620

Tian Medical Inc.Headache, Migraine

Start: 2017-09-20End: 2023-12-29Updated: 2024-01-05